We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

153 hedge funds and large institutions have $910M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 48 increasing their positions, 37 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

194% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 17

30% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 37

28% more capital invested

Capital invested by funds: $708M → $910M (+$201M)

26% more funds holding

Funds holding: 121 → 153 (+32)

14% more call options, than puts

Call options by funds: $6.41M | Put options by funds: $5.59M

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

Holders
153
Holders Change
+32
Holders Change %
+26.45%
% of All Funds
4.01%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.24%
New
50
Increased
48
Reduced
37
Closed
17
Calls
$6.41M
Puts
$5.59M
Net Calls
+$811K
Net Calls Change
+$12.5M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$21.6M
2
Norges Bank
Norges Bank
Norway
+$20.4M
3
FCH
Freestone Capital Holdings
Washington
+$16.2M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$14M
5
BIT
BlackRock Institutional Trust
California
+$13.9M

Top Sellers

1
FIM
Freedom Investment Management
Connecticut
-$28.6M
2
ICM
ISZO Capital Management
New York
-$25.9M
3
MCP
Moab Capital Partners
New York
-$11.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.53M
5
MICM
Matthews International Capital Management
California
-$5.32M
Name Holding Trade Value Shares
Change 		Change in
Stake
SGA
26
Strategic Global Advisors
California
$7.44M +$3.27M +22,383 +87%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$6.37M +$29.2K +200 +0.5%
PAM
28
Panagora Asset Management
Massachusetts
$6.37M +$3.4M +23,322 +130%
MPM
29
Meritage Portfolio Management
Kansas
$6.33M -$33.6K -230 -0.6%
Morgan Stanley
30
Morgan Stanley
New York
$6.11M -$62.3K -427 -1%
RFC
31
Russell Frank Company
Washington
$6.09M +$1.42M +9,731 +33%
AIIMS
32
Analyst IMS Investment Management Services
Israel
$5.09M – – –
Marshall Wace
33
Marshall Wace
United Kingdom
$4.91M +$339K +2,322 +8%
Ohio Public Employees Retirement System (OPERS)
34
Ohio Public Employees Retirement System (OPERS)
Ohio
$4.9M +$1.18M +8,095 +34%
Fidelity Investments
35
Fidelity Investments
Massachusetts
$4.64M -$6.53M -44,700 -60%
JAM
36
Jupiter Asset Management
United Kingdom
$4.64M – – –
AllianceBernstein
37
AllianceBernstein
Tennessee
$4.63M +$353K +2,421 +9%
Swiss National Bank
38
Swiss National Bank
Switzerland
$4.56M +$4.31M +29,500 New
MCP
39
Moab Capital Partners
New York
$4.51M -$11.8M -80,482 -73%
VCAM
40
Valentine Capital Asset Management
California
$4.39M -$769K -5,265 -16%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$4.24M – – –
CHAM
42
Clear Harbor Asset Management
Connecticut
$3.6M +$4.38K +30 +0.1%
Korea Investment Corp
43
Korea Investment Corp
South Korea
$3.38M +$3.2M +21,900 New
SLG
44
Stanley-Laman Group
Pennsylvania
$3.31M +$53.6K +367 +2%
BG
45
BlackRock Group
United Kingdom
$3.18M +$3.01M +20,596 New
VRS
46
Virginia Retirement Systems
Virginia
$3.06M +$2.89M +19,800 New
HHC
47
Hutchin Hill Capital
New York
$2.95M +$321K +2,200 +13%
AP
48
AHL Partners
United Kingdom
$2.9M +$2.22M +15,189 +421%
Barclays
49
Barclays
United Kingdom
$2.89M +$2.69M +18,435 +5,267%
CIBC Asset Management
50
CIBC Asset Management
Ontario, Canada
$2.86M -$504K -3,455 -16%
1
2
3 4 5

TARO Hedge Fund Activity: Q4 2015 in Review

153 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2015, worth a combined $910M — up 28% from $708M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new TARO positions and 17 closed out — a net gain of 33 holders — while 48 added to existing stakes and 37 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $21.6M. The largest seller was Freedom Investment Management, cutting an estimated $28.6M.

  • 153 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2015, up from 121 in Q3 2015.
  • Funds reported $910M of Taro Pharmaceutical Industries Ltd. stock for Q4 2015, up 28% quarter-over-quarter.
  • 50 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2015 and 17 closed out, a net change of +33 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2015 was Goldman Sachs, an estimated $21.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2015 was Freedom Investment Management, an estimated $28.6M sold.

Based on aggregated 13F filings for Q4 2015.